Current Research Studies

A Phase 1/2, Multicenter, Open-Label Study to Investigate the Safety, Tolerability, and Efficacy of a Single Intravenous Dose of SGT-003 in Ambulant Males with Duchenne Muscular Dystrophy

INSPIRE DUCHENNE

Phase: I/II
Clinicaltrials.gov ID: NCT06138639

What is the goal of the study?

A Study of SGT-003 Gene Therapy in Duchenne Muscular Dystrophy

Who can participate in the study?

Please contact the study team listed below to learn more.

Study Team:

PI (Study Doctor): Alicia Henriquez
Study Team Member: Janaki O’Brien, [email protected]